跳至主要内容
临床试验/NCT04440618
NCT04440618Unknown不适用

Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined Chemoradiotherapy

Poitiers University Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年7月30日最近更新:
适应症

试验速览

阶段
不适用
入组人数
30
试验地点
1
主要终点
Prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy.

研究概览

简要总结

The study's aim is to determinate the prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy in a locally advanced stages treated population of oropharyngeal cancer. Indeed, the level of knowledge about the consequences of oropharyngeal cancer treatment on sleep quality remains poor but the few studies published on the subject suggest an increased risk of development of OSAHS for these patients.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age> 18 years old
  • Performance Status 0-2
  • Squamous cell carcinoma of the oropharynx treated with concomitant chemoradiotherapy
  • Treatment termination time greater than 6 months at inclusion
  • Tumor classification (American Joint Committee on Cancer 8th) T2-T4 N0-N3
  • Patient in complete remission at inclusion
  • patient's consent's obtained after information

排除标准

  • Previous treatment for upper aerodigestive tract cancer
  • Incomplete radiotherapyTreatment
  • Neurological pathology wich may affect the functions of the upper aerodigestive tract
  • Pregnant or breastfeeding woman
  • Unweaned alcoholism
  • Tracheotomized patient at the time of the study
  • Patient under protection: subjects with guardianship or under law protection
  • No health insurance coverage

结局指标

主要结局

Prevalence of obstructive sleep apnea hypopnea syndrome after treatment by combined chemoradiotherapy.

时间窗: Day 28

Number of patients with obstructive sleep apnea hypopnea syndrome after treatment combined chemoradiotherapy.

次要结局

  • Severity of OSAHS as a function of the post-therapeutic delay.(Day 28)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验